Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibiotics
Biotech
Spero speared by antibiotic flop, triggering 39% workforce cut
An interim analysis revealed a double blow to the oral antibiotic candidate, which both failed to beat placebo and showed signs of liver toxicity.
Nick Paul Taylor
Oct 30, 2024 6:30am
Florey launches with plan to keep our guts in check
Oct 1, 2024 7:00am
Basilea scores $268M BARDA funding for antifungals, antibiotics
Sep 19, 2024 7:45am
Crestone’s antibiotic beats vancomycin at treating C. diff
Sep 5, 2024 3:11pm
Chlamydia in gut cells could require new antibiotic approach
Sep 5, 2024 5:00am
AN2 halves head count, stops phase 3 trial after data disappoint
Aug 9, 2024 5:41am